FdaApplication
BLA 019991
Identifiers
- fda_app_no: BLA019991
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 1991-06-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOVOLIN 70/30 | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | 300UNITS/10ML (30UNITS/ML); 700UNITS/10ML (70UNITS/ML) | Injection |
| NOVOLIN 70/30 | — | 90UNITS/3ML (30UNITS/ML); 210UNITS/3ML (70UNITS/ML) | Injection |
2 products